Summary
- Current Price
- As of today, ANIK price is $12.79, up +16.91% on
- Current Price All-Time High
- ANIK price is currently -83.11% below its historical high of $75.72 set on
- Market Cap
- ANIK current market cap is $184M, down -27.67% year-over-year
- PE Ratio
- ANIK PE ratio is unknown
- Revenue
- ANIK current annual revenue is $119.91M, down -0.73% year-over-year
- Next Earnings
- The next earnings release for ANIK is on
Profile
| Metric | Value |
|---|---|
| Full Name | Anika Therapeutics, Inc. |
| Ticker | NASDAQ: ANIK |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | anika.com |
| Employees | 288 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $12.79 | ||
| Price, 1D Change | +16.91% | |
| $184M | ||
| - | ||
| - | ||
| 0.81 | ||
| $120M | ||
| Revenue, 1Y Change | -0.73% | |
| -$3.83 | ||
| EPS, 1Y Change | +32.09% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.83 | ||
| EPS Estimate | -$0.13 | |
| EPS Est. Change | +96.61% | |
| $119.91M | ||
| Revenue Estimate | $111.03M | |
| Revenue Est. Change | -7.41% | |
| $12.79 | ||
| Price Target | - | $16.00 |
| Price Tgt. Change | - | +25.10% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.60 | -$5.64 | -252.53% | |
| $0.10 | -$3.83 | -3,930.20% | |
| -$0.13 | N/A | +96.61% | |
| $0.26 | N/A | +106.79% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $165.10M | $120.79M | -26.84% | |
| $150.20M | $119.91M | -20.17% | |
| $111.03M | N/A | -7.41% | |
| $116.35M | N/A | -2.97% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -27.70% | ||
| -58.69% | ||
| -27.67% | ||
| -59.26% | ||
| -0.73% | ||
| -18.87% | ||
| +32.09% | ||
| -1,455.82% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $12.79 | ||
| $9.94 | ||
| SMA 200 vs Price | -22.25% | |
| $9.85 | ||
| SMA 50 vs Price | -23.00% | |
| 0.81 | ||
| $0.45 | ||
| 82.95 | ||
| 84.20% | ||
| 56.19% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $119.91M | ||
| -$3.83 | ||
| $76.00M | ||
| 63.38% | ||
| -$5.10M | ||
| -4.25% | ||
| -$8.83M | ||
| -47.02% | ||
| -$5.10M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 4.88 | ||
| 3.85 | ||
| - | ||
| 5 | ||
| 3.24 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.64 | ||
| 1.26 | ||
| -23.31 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $153.99M | ||
| $55.63M | ||
| $215.63M | ||
| $113.65M | ||
| $61.64M | ||
| $23.31M | ||
| $25.93M | ||
| $1.92M | ||
| $5.62M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $125.01M | ||
| $81.10M | ||
| $43.91M | ||
| $55.56M | ||
| $8.12M | ||
| $0.00 | ||
| $6.06M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $5.40M | ||
| -$8.33M | ||
| -$12.73M | ||
| $8.33M | ||
| -$2.93M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barrington Research | → | |
| Barrington Research | → | |
| Barrington Research | → | |
| Barrington Research | → | |
| Barrington Research | → | |
| Barrington Research | → | |
| Barrington Research | → | |
| Barrington Research | → | |
| Barrington Research | → | |
| Stephens & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ANIK
FAQ
What is the ticker symbol for Anika Therapeutics, Inc.?
The ticker symbol for Anika Therapeutics, Inc. is NASDAQ:ANIK
Does Anika Therapeutics, Inc. pay dividends?
No, Anika Therapeutics, Inc. does not pay dividends
What sector is Anika Therapeutics, Inc. in?
Anika Therapeutics, Inc. is in the Healthcare sector
What industry is Anika Therapeutics, Inc. in?
Anika Therapeutics, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Anika Therapeutics, Inc. based in?
Anika Therapeutics, Inc. is headquartered in United States
When did Anika Therapeutics, Inc. go public?
Anika Therapeutics, Inc. initial public offering (IPO) was on May 3, 1993
Is Anika Therapeutics, Inc. in the S&P 500?
No, Anika Therapeutics, Inc. is not included in the S&P 500 index
Is Anika Therapeutics, Inc. in the NASDAQ 100?
No, Anika Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Anika Therapeutics, Inc. in the Dow Jones?
No, Anika Therapeutics, Inc. is not included in the Dow Jones index
When was Anika Therapeutics, Inc. last earnings report?
Anika Therapeutics, Inc.'s most recent earnings report was on November 5, 2025
When does Anika Therapeutics, Inc. report earnings?
The next expected earnings date for Anika Therapeutics, Inc. is February 26, 2026
Data Sources & References
- ANIK Official Website www.anika.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/898437/000117184325007032/0001171843-25-007032-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/898437/000117184325001486/0001171843-25-001486-index.htm
- ANIK Profile on Yahoo Finance finance.yahoo.com/quote/ANIK
- ANIK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/anik